Alexander Freiherr von Hammerstein-Equord

2PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 31, 2026
Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population.

Moritz Weber, Alexander Freiherr von Hammerstein-Equord, Manuela Weinreich

Pageof 1

Frequent Collaborators

2 joint publications

Moritz Weber

2 joint publications

Stefan Andreas

2 joint publications

Achim Rittmeyer